Human Platelet Lysate, Pathogen-Reduced, GMP-Compliant

Description

Start experiments confidently with a reliable supply of ethically sourced, GMP-compliant, fibrinogen-depleted, and pathogen-reduced human platelet lysate (hPL) for the expansion of cells in vitro.

An alternative to fetal bovine serum (FBS), this growth factor-rich cell culture supplement is derived from healthy donor human platelets, and multiple donor units are pooled during manufacturing to minimize lot-to-lot variability. Heparin is not added during the manufacturing process and is not required for use of this product. An electron beam (e-beam) irradiation step is included in the manufacturing process for pathogen reduction.